AU:1AD Stock Latest News
Company AnnouncementsAdAlta receives U.S. orphan-drug designation for EW-0013d ago1AD
Company AnnouncementsAdAlta receives A$1.4 million additional R&D tax refund1w ago1AD
Company AnnouncementsAdAlta sets in‑person 2026 AGM and pushes digital communications3w ago1AD
Company AnnouncementsAdAlta Advances EW-001 Toward U.S. FDA Milestone and Australian Manufacturing3w ago1AD
Company AnnouncementsAdAlta gains tax boost as overseas EW-001 R&D wins Australian approval1M ago1AD
Company AnnouncementsAdAlta advances EW-001 towards FDA engagement and Australian manufacturing1M ago1AD
Company AnnouncementsAdAlta Gains Validation as Oribiotech Wins US$120m Cell Therapy Manufacturing Deal2M ago1AD
Company AnnouncementsAdAlta takes ‘East to West’ CAR-T strategy and EW-001 data to U.S. investors2M ago1AD
Company AnnouncementsAdAlta gains China real-world data boost as partner’s CAR-T wins special access nod2M ago1AD
Company AnnouncementsAdAlta updates ASX corporate governance disclosures for 20263M ago1AD
Company AnnouncementsAdAlta Releases Annual Report for Year Ended 30 June 20263M ago1ADCompany AnnouncementsAdAlta outlines global immunotherapy ambitions while flagging investment risks3M ago1AD
Company AnnouncementsAdAlta’s EW-001 CAR-T Shows Promising Survival and Response in Advanced Mesothelioma3M ago1AD
Company AnnouncementsAdAlta Posts Landmark Long-Term Responses in Mesothelioma CAR-T Trial3M ago1AD
Company AnnouncementsAdAlta Advances EW-001 CAR-T Program and AI-Driven East-to-West Strategy3M ago1AD
Company AnnouncementsAdAlta Seeks ASX Quotation for Major New Share and Option Issue4M ago1AD
Company AnnouncementsAdAlta Seeks ASX Quotation for Nearly 265 Million New Securities4M ago1AD

